Acute or Chronic Treatment with AG1478, a Selective Inhibitor of EGFR, also Attenuates Diabetes-induced Elevation in ROCK and ERK1/2 Signaling in the Mesenteric Vascular Bed. Here, EGFR is linked to diabetes mellitus.